VANCOUVER, British Columbia, Oct. 6, 2009 (GLOBE NEWSWIRE) -- biOasis Technologies Inc. (TSX-V:BTI) is pleased to announce that David Browning has agreed to advise the Company on its development programs for p97 diagnostic products.
VANCOUVER, British Columbia, Oct. 6, 2009 (GLOBE NEWSWIRE) -- biOasis Technologies Inc. (TSX-V:BTI) is pleased to announce that David Browning has agreed to advise the Company on its development programs for p97 diagnostic products.